GlassScriptPhysician profile
Phillip Michael Grigsby
NPI 1740716539
$9,686.00
in general payments reported to CMS, 2019-2025
10 companies · $373 in 2025
The $373 reported for 2025 was more than what 76% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,824 · 2023: $5,771 · 2024: $717 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,382 · Food and Beverage: $2,476 · Gift: $3.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,381.87 |
| Food and Beverage | $2,476.33 |
| Gift | $3.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,709.89 | 2023-2025 | Penumbra System, Benchmark, Red 72 |
| Stryker Corporation | $2,538.19 | 2022-2024 | Target |
| Medtronic, INC. | $2,143.09 | 2022-2025 | Pipeline, Solitaire X, Axium Primetm |
| Medical Device Business Services, INC. | $1,803.33 | 2023 | Trufill, Pulsar Vascular Pulserider Aneurysm Neck Reconstruction Device, Cerepak Uniform |
| Imperative Care, INC | $149.29 | 2022 | |
| Depuy Synthes Sales INC. | $107.05 | 2024 | Trufill |
| Boston Scientific Corporation | $85.81 | 2022 | |
| Abbott Laboratories | $55.71 | 2022-2025 | Acculink |
| Microvention, INC. | $48.04 | 2023 | Web Aneurysm Embolization System, Stent |
| Balt USA, LLC | $45.60 | 2023 | Eclipse 2l |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Grigsby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.